BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for MEI Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-02-11 5:29 pm Sale |
2020-12-31 | 13G | MEI Pharma, Inc. MEIP |
BIOTECHNOLOGY VALUE FUND L P | 279,466 4.900% |
-64,856![]() (-18.84%) |
Filing |